BRIEF-Attenua, A Clinical-Stage Biopharma Company, Says Announced Completion Of $35 Million Series A Financing
Reuters Staff
1 Min Read
April 30 (Reuters) - ATTENUA:
* ATTENUA, A CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY, SAYS ANNOUNCED COMPLETION OF $35 MILLION SERIES A FINANCING Source text for Eikon: (Reuters.Briefs@thomsonreuters.com)